add round 2 abstract

model-abstract/README.md

@@ -0,0 +1,68 @@
+# Model Abstract
+
+This folder contains abstract files per round for team-models submitting to the 
+Scenario Modeling Hub. 
+
+----
+
+## Subdirectory
+
+Each sub-directory within the [model-abstract/](./) directory has the
+format:
+
+    team-model
+
+where 
+
+- `team` is the abbraviated teamname (`team_abbr`) and 
+- `model` is the abbreviated name of your model (`model_abbr`). 
+
+Both team and model should be less than 15 characters, and not include
+hyphens nor spaces.
+
+The `team-model` should correspond to the `team-model` sub-directory in the
+associated model-output folder containing the associated projections. 
+
+----
+
+## Template
+
+Each abstract is associated with a specific round. A template of 
+the expected abstract format is available in the 
+[template/](./template/) folder.
+
+
+## Abstract file 
+
+Each abstract file within the subdirectory should have the following 
+name
+
+    YYYY-MM-DD-team-model.md
+
+where
+
+- `YYYY` is the 4 digit year,
+- `MM` is the 2 digit month,
+- `DD` is the 2 digit day,
+- `team` is the teamname, and
+- `model` is the name of your model.
+
+The date YYYY-MM-DD should correspond to the start date for scenarios
+projection ("first date of simulated transmission/outcomes" as noted in the
+scenario description on the main 
+[README, Submission Information](https://github.com/midas-network/rsv-scenario-modeling-hub)).
+
+Please keep the sections (or headings), lines starting with `#`, as 
+they are in the templates and only change spaces marked with `FILL`.
+All markdown associated format is accepted, except the addition of other 
+sections (or headings).
+
+For more information on the markdown format, please consult the 
+[GitHub - Basic writing and formatting syntax help page](https://docs.github.com/en/get-started/writing-on-github/getting-started-with-writing-and-formatting-on-github/basic-writing-and-formatting-syntax)
+
+### Examples
+
+The [model-abstract/](./) contains an example abstract file from 
+a `team2-modelb` team. The abstract file associated with the example
+is a copy of a template file, the example here is mainly design
+to illustrate the organization of the folder and the file naming system. 

model-abstract/team2-modelb/2024-07-28-team2-modelb.md

@@ -0,0 +1,54 @@
+## Summary of Results
+FILL
+
+## General Model Description
+FILL
+
+## Explanation of observed dynamics given model assumptions 
+FILL
+
+## Model Calibration
+
+### General calibration approach
+FILL
+
+### Was the model calibrated to 2023-24 data, and if so how? And how was the counterfactual scenario generated?
+FILL
+
+## Model Assumptions
+
+### **Immunity assumptions** (describe protection against infection and severe disease, duration of immunity and waning distributions)
+
+#### Immunity after natural infection
+FILL
+
+#### Maternal immunity
+FILL
+
+#### Immunity from maternal vaccines
+FILL
+
+#### Immunity from nirsevimab
+FILL
+
+#### Immunity from senior vaccines
+FILL
+
+### **Seasonality implementation**
+FILL
+
+### **Initial Conditions**
+FILL
+
+### **Age groups considered** (especially within under 1 yo, and whether within season aging is considered)
+FILL
+
+### **Geography**
+
+#### State-stratification details (prior immunity, seasonality, severity/reporting)
+FILL
+
+#### Process to generate national projections (separate model fitted to US data vs aggregation of projection from RSVnet states)
+FILL
+
+### **Other Model Assumptions**

model-abstract/template/2024-07-28.md

@@ -0,0 +1,54 @@
+## Summary of Results
+FILL
+
+## General Model Description
+FILL
+
+## Explanation of observed dynamics given model assumptions 
+FILL
+
+## Model Calibration
+
+### General calibration approach
+FILL
+
+### Was the model calibrated to 2023-24 data, and if so how? And how was the counterfactual scenario generated?
+FILL
+
+## Model Assumptions
+
+### **Immunity assumptions** (describe protection against infection and severe disease, duration of immunity and waning distributions)
+
+#### Immunity after natural infection
+FILL
+
+#### Maternal immunity
+FILL
+
+#### Immunity from maternal vaccines
+FILL
+
+#### Immunity from nirsevimab
+FILL
+
+#### Immunity from senior vaccines
+FILL
+
+### **Seasonality implementation**
+FILL
+
+### **Initial Conditions**
+FILL
+
+### **Age groups considered** (especially within under 1 yo, and whether within season aging is considered)
+FILL
+
+### **Geography**
+
+#### State-stratification details (prior immunity, seasonality, severity/reporting)
+FILL
+
+#### Process to generate national projections (separate model fitted to US data vs aggregation of projection from RSVnet states)
+FILL
+
+### **Other Model Assumptions**